Diabetes decisions — 2022

The Board has denied the Veteran's claims for service connection for diabetes mellitus and bilateral neuropathy of the lower extremities, finding that there is no evidence to support these claims.

The Veteran's service connection claims for diabetes mellitus, type II; prostate cancer; precancerous colon mass; and atrial fibrillation have been denied as there is no evidence of herbicide exposure during service.,Service connection was not granted due to lack of actual or presumptive exposure to Agent Orange.

The Veteran's service-connected disabilities did not preclude him from securing and following substantially gainful employment prior to February 23, 2017.

The Board has remanded the claims for diabetes, back condition, glaucoma, GERD, right shoulder condition, and left femur condition due to insufficient evidence on whether these conditions are related to service. The Veteran is competent to report his symptoms in service.

The Board denied the Veteran's claims for service connection for diabetes mellitus, peripheral neuropathy of the bilateral lower extremities, and a pulmonary lung condition. The decision found that new and material evidence was not received to reopen any of these claims.

The Board has remanded the claims for diabetes mellitus, diabetic neuropathy, hypertension, and a lumbosacral spine disability due to in-service exposure to an herbicide agent (Agent Orange). The Veteran's service treatment records are unavailable through no fault of his own. Further efforts to obtain these records would be futile. The Board also found that the Veteran was not exposed to Agent Orange during active service, and thus denied service connection for these conditions.

The Veteran's diabetes mellitus, type II is rated at 20 percent. His right and left lower extremity peripheral neuropathy are each rated at 10 percent prior to October 26, 2018, and 20 percent thereafter. The Board has remanded the issue of service connection for obstructive sleep apnea as secondary to other service-connected conditions.

The Board denied service connection for a left shoulder disability and denied increased ratings for DMII with retinopathy and erectile dysfunction. The Veteran's current conditions are not related to his active duty service, and the criteria for higher ratings under the applicable diagnostic codes were not met.

The Board denied the Veteran's claims of service connection for hypertensive heart disease, cirrhosis of the liver, diabetes mellitus, and chronic kidney disease. The Board found no evidence of herbicide exposure during service and insufficient medical evidence to establish a link between these conditions and service.

The Board has remanded the Veteran's claims for service connection for diabetes mellitus, type II (DMII), hypertension, and peripheral neuropathy of the upper and lower extremities due to potential exposure to herbicide agents in Vietnam. The claims are also remanded for further examination regarding his right wrist disorder, bilateral ankle disorders, right hip disorder, and left knee disorder.

The Veteran is granted entitlement to TDIU and SMC based on housebound status prior to September 28, 2009 due to his service-connected psychiatric disorder and other disabilities rated at least 60 percent combined.

The Veteran's claim for service connection for diabetes was denied as there is no evidence of a current diagnosis.,Service connection for tinnitus was granted based on the Veteran's credible account of in-service noise exposure and continuity of symptoms.

The Board has decided to remand the Veteran's claim for service connection of diabetes mellitus type II due to inadequate compliance with previous remand directives. A supplemental opinion is needed from a VA medical professional to address the etiology of the Veteran's diabetes and reconcile the evidence submitted by the Veteran in May 2018.

The Veteran's service-connected diabetic peripheral neuropathy of the lower extremities, specifically sciatic and femoral nerves, has been granted increased ratings to 40 percent for each affected nerve.

The Veteran's claim for increased ratings and service connection is being remanded due to the need for additional development, including obtaining an addendum medical opinion.

The Board has remanded the claims for service connection for hypertension, diabetes mellitus, peripheral neuropathy of all four extremities, and erectile dysfunction due to conflicting evidence and need for further clarification.

The Board has decided that the Veteran's claim for service connection for glaucoma, as secondary to his service-connected diabetes mellitus type II, needs further clarification and evidence. The case is being sent back to the VA examiner who conducted a previous examination.

The Veteran's claim for service connection for diabetes mellitus, type II has been denied. The Board found that the evidence did not support a finding of secondary service connection and concluded that the condition was not related to his service-connected coronary artery disease or hypertension.

The Board denied a higher rating for the Veteran's right ankle disability and denied service connection for diabetes mellitus type II. The right ankle disability was rated at 10 percent, effective December 27, 2016.

The Board has granted an effective date of May 4, 2011 for the grant of service connection for diabetes mellitus type II due to presumptive exposure to Agent Orange. The original denial was based on lack of evidence of Vietnam service, but subsequent VA records confirmed the Veteran's service in Vietnam and thus the presumption applied.